TP53 and neuroblastoma: To this end, the present study assessed whether RG7388 synergises with 5 chemotherapy agents most commonly used during frontline treatment at diagnosis or relapse, namely cisplatin, doxorubicin, topotecan (induction), busulfan (consolidation) and temozolomide (relapse) in 5 p53 wt neuroblastoma cell lines.